Efficacy of doxycycline as a combination therapy in the treatment of rheumatoid
Doxycycline as a cost-effective combination therapy with MTX can achieve higher rates of remission than MTX alone in RA patients without causing increase in the adverse events profile.
https://ejim.springeropen.com/articles/10.1186/s43162-021-00032-5